Suchergebnisse - "Minami, Hironobu"

PubPharm (608)

51

Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study

enthalten in: International journal of hematology | 2022

von Fukuhara, N. | Maruyama, D. | Hatake, K. | +18

52

Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study

enthalten in: International journal of hematology | 2022

von Fukuhara, N. | Maruyama, D. | Hatake, K. | +18

53

Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer : Primary results and biomarker data from a phase 2 trial (WJOG9917B)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Ozaki, Y. | Tsurutani, J. | Mukohara, T. | +11

54

Liposomal irinotecan (Onivyde) : Exemplifying the benefits of nanotherapeutic drugs

enthalten in: Cancer science | 2022

von Milano, G. | Innocenti, F. | Minami, H.

55

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

enthalten in: Vaccines | 2022

von Funakoshi, Y. | Yakushijin, K. | Ohji, G. | +15

56

Efficacy and safety of blinatumomab : Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

enthalten in: Asia-Pacific journal of clinical oncology | 2022

von Kobayashi, Y. | Oh, I. | Miyamoto, T. | +11

57

Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer

enthalten in: bioRxiv.org | 2022

von Funakoshi, Y. | Yakushijin, K. | Ohji, G. | +15

58

Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in Japanese patients after allogeneic stem cell transplantation

enthalten in: bioRxiv.org | 2022

von Watanabe, M. | Yakushijin, K. | Funakoshi, Y. | +17

59

Promising efficacy of following a third dose of mRNA SARS-CoV-2 vaccination in patients treated with anti-CD20 antibody who failed 2-dose vaccination

enthalten in: bioRxiv.org | 2022

von Funakoshi, Y. | Yakushijin, K. | Ohji, G. | +15

60

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge

enthalten in: Molecular and clinical oncology | 2022

von Nose, T. | Funakoshi, Y. | Suto, H. | +5